Author(s):Professor John O'Brien, Dr Vanessa Raymont, Dr Ross Dunne, Dr Ben Underwood
This session will review potential treatment strategies for dementia based on inflammation, protein handling, glucose metabolism and tau phosphorylation and clinical trials which target these.
Chair: Professor John O'Brien, University of Cambridge
Inflammation as a therapeutic target in alzheimer's disease - Dr Vanessa Raymont, University of Oxford
Lithium and other inhibitors of tau phosphorylation - Dr Ross Dunne, University of Manchester
Protein production, degradation and glucose metabolism -Dr Ben Underwood, University of Cambridge
Find more content